Market Tracker

12/09 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

26.76
Delayed Data
As of Dec 09
 -0.48 / -1.76%
Today’s Change
16.64
Today|||52-Week Range
42.49
-24.94%
Year-to-Date
3 Beaten-Up Biotech Stocks: Are They Bargains?
Dec 09 / MotleyFool.com - Paid Partner Content
3 Biotechs With Save-the-Date Catalysts on Tap
Nov 29 / MotleyFool.com - Paid Partner Content
Here's Why ACADIA Pharmaceuticals Jumped 17.7% in November
Dec 05 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close27.24
Today’s open27.22
Day’s range26.61 - 27.84
Volume1,410,533
Average volume (3 months)2,334,478
Market cap$3.3B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-43.19%
Earnings growth (next 5 years)+16.76%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book13.90

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...-2.09-1.76%
ENDPEndo International P...-0.01-0.06%
ALNYAlnylam Pharmaceutic...+1.45+3.54%
CTLTCatalent Inc+0.19+0.78%
Data as of 4:01pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts